SE427419B - Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen - Google Patents

Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen

Info

Publication number
SE427419B
SE427419B SE7711422A SE7711422A SE427419B SE 427419 B SE427419 B SE 427419B SE 7711422 A SE7711422 A SE 7711422A SE 7711422 A SE7711422 A SE 7711422A SE 427419 B SE427419 B SE 427419B
Authority
SE
Sweden
Prior art keywords
grespollen
antigent
antigen
preparing
complex
Prior art date
Application number
SE7711422A
Other languages
English (en)
Swedish (sv)
Other versions
SE7711422L (sv
Inventor
A Malley
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of SE7711422L publication Critical patent/SE7711422L/xx
Publication of SE427419B publication Critical patent/SE427419B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7711422A 1976-10-12 1977-10-11 Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen SE427419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/731,414 US4140679A (en) 1976-10-12 1976-10-12 Antigen-protein complex for blocking allergic reactions

Publications (2)

Publication Number Publication Date
SE7711422L SE7711422L (sv) 1978-04-13
SE427419B true SE427419B (sv) 1983-04-11

Family

ID=24939399

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7711422A SE427419B (sv) 1976-10-12 1977-10-11 Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen
SE8205313A SE8205313D0 (sv) 1976-10-12 1982-09-16 Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8205313A SE8205313D0 (sv) 1976-10-12 1982-09-16 Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav

Country Status (17)

Country Link
US (2) US4140679A (fr)
JP (1) JPS5347516A (fr)
AU (1) AU510639B2 (fr)
BE (1) BE859620A (fr)
CA (1) CA1099258A (fr)
CH (1) CH636524A5 (fr)
DE (1) DE2744983A1 (fr)
DK (1) DK448677A (fr)
ES (1) ES463124A1 (fr)
FI (1) FI58501C (fr)
FR (2) FR2382458A1 (fr)
GB (2) GB1552056A (fr)
LU (1) LU78273A1 (fr)
NL (1) NL7711026A (fr)
NO (2) NO147860C (fr)
SE (2) SE427419B (fr)
ZA (1) ZA775742B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256732A (en) * 1978-08-15 1981-03-17 Research Corporation Modified grass pollen antigens
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
WO1981001145A1 (fr) * 1979-10-18 1981-04-30 Univ Illinois Medicaments "pro-drugs" pouvant etre actives par des enzymes hydrolytiques
US4469677A (en) * 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
JPS57501848A (fr) * 1980-10-08 1982-10-14
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
SE8303401D0 (sv) * 1983-06-15 1983-06-15 Pharmacia Ab Beredning och dess anvendning
US4702907A (en) * 1983-08-09 1987-10-27 Cornell Research Foundation, Inc. Process for inducing selective immunosuppression of antibodies
US5447722A (en) * 1983-12-12 1995-09-05 University Of Manitoba Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5026545A (en) * 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
US4740371A (en) * 1984-09-17 1988-04-26 International Institute Of Cellular And Molecular Pathology Treatment of allergy
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
CA2015515C (fr) 1990-01-03 1999-12-07 Jean-Marie Saint-Remy Composes pharmaceutiques contenant des complexes antigene-anticorps et leur utilisation
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
US5191066A (en) * 1990-12-07 1993-03-02 Abbott Laboratories Site-specific conjugation of immunoglobulins and detectable labels
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6656488B2 (en) * 2001-04-11 2003-12-02 Ethicon Endo-Surgery, Inc. Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO132132C (fr) * 1968-10-10 1975-09-24 David George Marsh
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
GB1578348A (en) * 1976-08-17 1980-11-05 Pharmacia Ab Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic

Also Published As

Publication number Publication date
GB1552056A (en) 1979-09-05
NO822838L (no) 1978-04-13
GB1552057A (en) 1979-09-05
NO147860B (no) 1983-03-21
CA1099258A (fr) 1981-04-14
FI58501C (fi) 1981-02-10
NO147860C (no) 1983-06-29
US4140679A (en) 1979-02-20
SE8205313L (sv) 1982-09-16
DE2744983A1 (de) 1978-04-13
FR2382458A1 (fr) 1978-09-29
ZA775742B (en) 1978-08-30
FI772945A (fi) 1978-04-13
BE859620A (fr) 1978-02-01
LU78273A1 (fr) 1978-01-23
CH636524A5 (fr) 1983-06-15
FR2382460B1 (fr) 1982-11-19
SE8205313D0 (sv) 1982-09-16
FR2382458B1 (fr) 1982-11-19
FR2382460A1 (fr) 1978-09-29
DK448677A (da) 1978-04-13
AU2915877A (en) 1979-04-05
FI58501B (fi) 1980-10-31
JPS5347516A (en) 1978-04-28
SE7711422L (sv) 1978-04-13
AU510639B2 (en) 1980-07-03
US4158705A (en) 1979-06-19
NL7711026A (nl) 1978-04-14
ES463124A1 (es) 1978-07-01
NO773465L (no) 1978-04-13

Similar Documents

Publication Publication Date Title
SE427419B (sv) Analogiforfarande for framstellning av ett antigent komplex for blockering av allergiska reaktioner mot grespollenantigen
SE436411B (sv) Fordonsdrivsystem
FI65861B (fi) Anordning foer genomfoering av ett radioimmunologiskt foerfarande
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE7704949L (sv) Forfarande for framstellning av emulsioner
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE7704689L (sv) Forfarande for framstellning av insulin
IT1078475B (it) Procedimento per produrre oligouretani
FI56536B (fi) Mot aktivitetsfoerlust stabiliserat ureaspreparat
IT1079640B (it) Procedimento per produrre idrossi benzaldeidi
SE428085B (sv) Forfarande for framstellning av mjukost
NL7513512A (nl) Werkwijze voor het produceren van gekleurde poly- alkeenvoorwerpen.
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE442588B (sv) Forfarande for framstellning av serumalbumin
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE442589B (sv) Forfarande for framstellning av serumalbumin
SE421921B (sv) Analogiforfarande for framstellning av pyridobensodiazepinoner
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
IT1079721B (it) Procedimento per produrre metildiclorofasfano
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE7704183L (sv) Forfarande for framstellning av polyolefiner
SE425490B (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner